|
SRFBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.429500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.063920E-03 |
| Normal-vs-Stage2 |
1.797050E-03 |
| Normal-vs-Stage3 |
1.204010E-03 |
| Normal-vs-Stage4 |
3.798200E-03 |
| Stage1-vs-Stage2 |
4.271200E-01 |
| Stage1-vs-Stage3 |
6.642400E-01 |
| Stage1-vs-Stage4 |
8.181200E-01 |
| Stage2-vs-Stage3 |
6.708400E-01 |
| Stage2-vs-Stage4 |
6.383800E-01 |
| Stage3-vs-Stage4 |
9.242800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.048100E-04 |
| Normal-vs-AfricanAmerican |
1.193600E-01 |
| Normal-vs-Asian |
1.257550E-03 |
| Caucasian-vs-AfricanAmerican |
4.805000E-01 |
| Caucasian-vs-Asian |
4.842200E-01 |
| AfricanAmerican-vs-Asian |
2.682000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54888999999159E-05 |
| Normal-vs-Female |
2.242900E-03 |
| Male-vs-Female |
4.861900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.878200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.182590E-04 |
| Normal-vs-Age(61-80Yrs) |
1.242980E-03 |
| Normal-vs-Age(81-100Yrs) |
7.543700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.939630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.902200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.875800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.391800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.986800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.407000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.130000E-01 |
| Classical-VS-Follicular |
2.355300E-04 |
| Classical-VS-Other |
1.253590E-01 |
| Classical-VS-Normal |
8.944000E-03 |
| Tall-VS-Follicular |
4.937200E-03 |
| Tall-VS-Other |
7.936300E-02 |
| Tall-VS-Normal |
2.165600E-01 |
| Follicular-VS-Other |
7.492800E-01 |
| Follicular-VS-Normal |
8.32470000045049E-07 |
| Other-VS-Normal |
1.269630E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04179999999665E-05 |
| Normal-vs-N1 |
1.635620E-02 |
| N0-vs-N1 |
2.475800E-01 |
|
|
